In Vitro Susceptibility Testing of GSK656 against Mycobacterium Species
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Susceptibility Testing of GSK656 against Mycobacterium Species
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2019-12-03
DOI
10.1128/aac.01577-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China
- (2018) Caihong Xu et al. JOURNAL OF INFECTION
- Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
- (2018) Simon Tiberi et al. LANCET INFECTIOUS DISEASES
- SWISS-MODEL: homology modelling of protein structures and complexes
- (2018) Andrew Waterhouse et al. NUCLEIC ACIDS RESEARCH
- In vitro activity of PBTZ169 against multiple Mycobacterium species
- (2018) Jin Shi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study
- (2017) Yu Pang et al. EUROPEAN RESPIRATORY JOURNAL
- In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense
- (2017) Zhijian Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
- (2017) Xianfeng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- The global tuberculosis situation and the inexorable rise of drug-resistant disease
- (2016) Ben J. Marais ADVANCED DRUG DELIVERY REVIEWS
- Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
- (2016) Andrés Palencia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
- (2015) Julie V. Philley et al. CHEST
- Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China
- (2015) Zhijian Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China
- (2014) Zhijian Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
- (2013) Wouter Hoefsloot et al. EUROPEAN RESPIRATORY JOURNAL
- Mycobacterium abscessus: a new antibiotic nightmare
- (2012) R. Nessar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A novel method based on high resolution melting (HRM) analysis for MIRU–VNTR genotyping of Mycobacterium tuberculosis
- (2011) Yu Pang et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Differences in Cell Wall Thickness between Resistant and Nonresistant Strains of Mycobacterium tuberculosis: Using Transmission Electron Microscopy
- (2009) Ali Akbar Velayati et al. CHEMOTHERAPY
- Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients
- (2008) Claudio Piersimoni et al. LANCET INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started